Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05008458
Other study ID # soh-med-21-07-16
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date May 15, 2022

Study information

Verified date August 2021
Source Sohag University
Contact mahmoud a abd elrady, resident
Phone 01276923636
Email mahmoud011175@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Febrile seizures are one of the most common clinical diseases in pediatric neurology. It occurs between 6 months and 6 years of age and occurs in ~2-5% of children. According to the age, frequency, duration, and type of seizures FS is divided into simple febrile seizures and complex febrile seizures Differentiation between febrile seizures and non-ictal events associated with fever such as shivering or dizziness is challenging. Therefore, precise diagnosis of FS after paroxysmal episodes associated with fever is often hindered by the lack of an objective biomarker With the widespread application of technologies, such as molecular biology, in medicine, some biomarkers for predicting or diagnosing FS have attracted attention. Imuekemhe et al in 1989 and 1996 found that lactic acid in the serum and cerebrospinal fluid of children with FS was significantly increased . Arginin-vasopressin hormone AVP released by the pituitary gland, has been shown to be involved in the thermoregulatory response to fever and convulsions Although AVP is unstable in the peripheral blood and, therefore, unsuited for diagnostic use the C-terminal portion of the AVP precursor copeptin has been recognized as a robust marker of AVP secretion . Wellman et al. found that the serum copeptin and Von Willebrand factor of children with FS were significantly higher than those of the control group .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date May 15, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 6 Years
Eligibility Inclusion Criteria: - Age from 6 months to 6 years. - Seizures. - Fever (=38°C). Exclusion Criteria: - Central nervous system infection. - Epilepsy. - Previous neurological abnormalities. - Inborn errors of metabolism. - Immunological diseases. - Endocrinal diseases (e.g., diabetes mellitus). - Obesity. - Eating disorders. - Gastrointestinal disorders (e.g., diarrhea).

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
von willebrand factor and copeptin
biomarkers increase in children with febrile seizures

Locations

Country Name City State
Egypt Sohag University Hospital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Leung AK, Hon KL, Leung TN. Febrile seizures: an overview. Drugs Context. 2018 Jul 16;7:212536. doi: 10.7573/dic.212536. eCollection 2018. Review. — View Citation

Patel N, Ram D, Swiderska N, Mewasingh LD, Newton RW, Offringa M. Febrile seizures. BMJ. 2015 Aug 18;351:h4240. doi: 10.1136/bmj.h4240. Review. — View Citation

Pechmann A, Wellmann S, Stoecklin B, Krüger M, Zieger B. Increased von Willebrand factor parameters in children with febrile seizures. PLoS One. 2019 Jan 3;14(1):e0210004. doi: 10.1371/journal.pone.0210004. eCollection 2019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Value of von willebrand factor and copeptin assay in children with febrile seizures at Sohag University Hospital Serum copeptin and Von Willebrand factor (VWF) venous blood samples (3 ml) will be obtained from children with FS (within 3 hours of seizures) as well as the two control groups. . one year
See also
  Status Clinical Trial Phase
Completed NCT03481764 - Anthropogenetic Variability in the Group of Individuals With Febrile Seizures
Completed NCT04368936 - Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Not yet recruiting NCT05947006 - Study of the Impact of a Pediatric Nurse's Consultation on Parental Anxiety During a Febrile Convulsion in Children N/A
Recruiting NCT05215366 - Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT03165981 - Fever After Simultaneous Versus Sequential Vaccination in Young Children Phase 4
Completed NCT04967066 - A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
Terminated NCT01370044 - Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures Phase 2/Phase 3